Pharmaceutical Analysis & Statistics in Germany, May 2013 (p8)

You might be interested in: therapeutics, drug, cancer, more »

211-260 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While the increased consumption of generic medicines will have an impact on the overall pharmaceutical industry projection for Germany, we note that government ...

  • Industries : Drug and Medication
  • Countries : Germany
MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • May 2014
  • by Global Data

MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...

  • Industries : Pathology
  • Countries : France, Italy, Germany, Spain, United Kingdom, Europe
Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

  • $ 22 464
  • Industry report
  • May 2014
  • by Global Research & Data Services

The expansion of the global vitamin and provitamin industry is forecast to reach 2.6% p.a. in the coming years. Between 2007 and 2013 the market increased with an average annual growth of 8.0%. Currently, ...

  • Industries : Vitamin and Supplement
  • Countries : United States, World, Europe, Asia, South America, North America, Czech Republic, South Korea, Philippines, Netherlands, Singapore, Panama, Slovenia, Slovakia (slovak Republic), Belgium, Japan, India, China, Australia, Argentina, United Kingdom, Macedonia, Lithuania, Sri Lanka, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Mexico, Canada, Ukraine, Sweden, Spain, Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt
Vitamin and Provitamin Market in Germany to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Market in Germany to 2018 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • May 2014
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for vitamins and provitamins in Germany. The research includes historic market data ...

  • Industries : Vitamin and Supplement
  • Countries : Germany
MediGene AG (MDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MediGene AG (MDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary MediGene AG (MediGene) is a biotechnology company. It carries out clinical research, development and marketing of novel drugs for the treatment of cancer and autoimmune diseases. The company's ...

  • Industries : Pathology
  • Countries : Germany
Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

  • $ 4 650
  • Industry report
  • May 2014
  • by MarketsandMarkets

The mold inhibitors market is expected to grow at a CAGR of 2.9% from 2014 to 2019. The estimation is made on the basis of the increasing health awareness among consumers as mold causes allergies, asthma, ...

  • Industries : Drug and Medication
  • Countries : World, North America, Europe, China, Mexico, Canada, India, South Africa, Brazil, France, Germany, Japan, United States
Emergent BioSolutions Inc. (EBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emergent BioSolutions Inc. (EBS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Emergent BioSolutions Inc. (Emergent) is a global specialty pharmaceutical company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. ...

  • Industries : Drug and Medication
  • Countries : United States, Germany
PharmaZell GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PharmaZell GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary PharmaZell GmbH (PharmaZell) is a pharmaceutical company. It focuses on development and production of generic Active Pharmaceutical Ingredients (API) and intermediates. It also offers formulation ...

  • Industries : Pharmaceutical
  • Countries : Germany
Pharmaceuticals - World Market Group of Eight (G8) Market Overview (Market size, Segmentation and Trends Analysis)

Pharmaceuticals - World Market Group of Eight (G8) Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 1 495
  • Industry report
  • May 2014
  • by MarketLine

The market research report includes easily comparable data on industry value, volume, key market segments and industry share, plus full 5 year industry forecasts . It examines future problems, innovations ...

  • Industries : Pharmaceutical
  • Countries : Germany, Japan, World, United States, Canada, Russian Federation, Italy, France, United Kingdom, Europe
EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • May 2014
  • by Global Data

EpiCast Report: Non-Hodgkin's Lymphoma - Epidemiology Forecast to 2023 Summary Non-Hodgkin's lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body's immune ...

  • Industries : Pathology
  • Countries : United States, Germany, World, United Kingdom, Spain, Italy, France
MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • May 2014
  • by Global Data

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...

  • Industries : Pathology
  • Countries : World, France, China, Italy, Japan, Brazil, Germany, India, Spain, United Kingdom, United States, Europe
EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • May 2014
  • by Global Data

EpiCast Report: Chronic Lymphocytic Leukemia - Epidemiology Forecast to 2023 Summary Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood ...

  • Industries : Pathology
  • Countries : United States, France, World, Spain, Italy, Germany
Manufacture Of Pharmaceutical Products (Germany)

Manufacture Of Pharmaceutical Products (Germany)

  • $ 869
  • Industry report
  • May 2014
  • by Plimsoll Publishing Ltd UK

Plimsoll Publishing's MANUFACTURE OF PHARMACEUTICAL PRODUCTS (Germany) Analysis provides a detailed overview of the MANUFACTURE OF PHARMACEUTICAL PRODUCTS (Germany) market and delivers a comprehensive ...

  • Industries : Pharmaceutical
  • Countries : Germany
MarketVIEW: Group B Streptococcus

MarketVIEW: Group B Streptococcus

  • $ 4 495
  • Industry report
  • May 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Group B beta streptococci (GBS) or Streptococcus agalactiae is an encapsulated Gram-positive coccus capable of producing a range of diseases in humans of all age ranges. In the neonate, the bacterium can ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Africa, Brazil, Mexico, Canada, United Kingdom, Spain, Italy, France, Germany, Europe, North America
PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Italy, Spain, France, Germany, United Kingdom, Europe, World
Pharmaceuticals in Germany, MarketLine

Pharmaceuticals in Germany, MarketLine

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The ...

  • Industries : Pharmaceutical
  • Countries : Germany
DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022

DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022

Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Cymbalta (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Topical Clonidine (Neuropathic Pain) - Forecast and Market Analysis to 2022

Topical Clonidine (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Topical Clonidine (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022

Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, World, United States, United Kingdom, Europe
CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022

CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, World, United States, United Kingdom, Europe
About 400 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in the US and Germany

  • William A. Gray and Juan F. Granada
  • September 2014
    10 pages
  • Drug And Medica...  

    Drug  

  • United States  

    Germany  

View report >

Tire Industry In Germany

September 2014

Valve Industry In Germany

September 2014

Drug Industry In Germany

September 2014

11 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.